Breaking News Instant updates and real-time market news.

AXP

American Express

$119.00 /

-0.82 (-0.68%)

08:19
05/20/19
05/20
08:19
05/20/19
08:19

Stephens sees significant growth opportunity for AmEx in B2B payments

Stephens analyst Vincent Caintic, after hosting meetings with American Express management, said that he sees a significant opportunity for the company in the Business-To-Business, or B2B, space, particularly in payments to suppliers. The biggest challenge is signing suppliers to take American Express as a form of payment, but the company's current key value proposition is paying suppliers faster for accepting the card, Caintic explains. He keeps an Overweight rating and $131 price target on AmEx shares following the management meetings.

  • 03

    Jun

  • 13

    Nov

AXP American Express
$119.00 /

-0.82 (-0.68%)

05/15/19 SunTrust
Green Sky's loss of Regions as funding partner 'not material,' says SunTrust
05/03/19 RBC Capital
American Express assumed with a Sector Perform at RBC Capital
04/29/19
American Express downgraded to Neutral at UBS on limited earnings upside
04/29/19 UBS
American Express downgraded to Neutral from Buy at UBS

TODAY'S FREE FLY STORIES

Recommendations
Kraft debt downgrades assures higher borrowing costs, says Stifel » 13:05
02/17/20
02/17
13:05
02/17/20
13:05
KHC

Kraft Heinz

$26.88 /

-0.895 (-3.22%)

Stifel analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
General Motors to cease Holden sales, design/engineering operations by 2021 » 13:04
02/17/20
02/17
13:04
02/17/20
13:04
GM

General Motors

$34.76 /

-0.535 (-1.52%)

General Motors said it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
S&P lowers Kraft Heinz long-term issuer credit rating to 'BB+' » 13:01
02/17/20
02/17
13:01
02/17/20
13:01
KHC

Kraft Heinz

$26.88 /

-0.895 (-3.22%)

S&P Global Ratings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Summary: The pound ebbed some, and the Canadian dollar firmed some » 13:00
02/17/20
02/17
13:00
02/17/20
13:00

FX Summary: The pound…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Teva price target raised to $14 from $8 at UBS » 12:56
02/17/20
02/17
12:56
02/17/20
12:56
TEVA

Teva

$12.21 /

-0.36 (-2.86%)

UBS analyst Kevin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Infosys upgraded to Buy from Neutral at Goldman Sachs » 12:53
02/17/20
02/17
12:53
02/17/20
12:53
INFY

Infosys

$11.02 /

-0.08 (-0.72%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Bombardier sells rail business to Alstom for $8.2B » 12:48
02/17/20
02/17
12:48
02/17/20
12:48
BDRBF

Bombardier

$0.00 /

+ (+0.00%)

, ALSMY

Alstom

$0.00 /

+ (+0.00%)

Bombardier (BDRBF)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Siemens upgraded to Buy from Hold at Nord/LB » 12:43
02/17/20
02/17
12:43
02/17/20
12:43
SIEGY

Siemens

$0.00 /

+ (+0.00%)

Nord/LB analyst Wolfgang…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Oil Action: Front-month WTI prices are flat » 09:45
02/17/20
02/17
09:45
02/17/20
09:45

Oil Action: Front-month…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: The dollar and most other currencies have been stable » 07:55
02/17/20
02/17
07:55
02/17/20
07:55

FX Update: The dollar and…

FX Update: The dollar and most other currencies have been stable in quiet early-week trading so far. This came with the main Chinese equity indices posting 2%-plus gains after China's Finance Minister said on Sunday that Beijing would roll out targeted and phased tax and fee cuts and with the PBoC lowering one of its interest rates and making another liquidity injection. Other stock markets in Asia were mixed, while European markets posted modest gains. The number of new cases in the coronavirus continued to increase, though the consensus view seems to remain that peak contagion will likely been seen in March. Japan's Nikkei 225 underperformed, closing with a 0.7% loss following weaker than expected Q4 GDP data, which showed a 1.6% q/q contraction versus the median forecast for -0.9%. Q3 data were also revised down, and the data come amid expectations for a dismal current quarter performance given the impact of measures to contain the virus outbreak in China and Japan, and elsewhere. Among the main currencies, EUR-USD has been plying a narrow range just above the 34-month seen on Friday at 1.0827. USD-JPY has posted a sub-15 pip range just below Friday's 107.91 peak so far. Cable has continued to consolidate gains seen mid last week following signs that the government is gearing up a fiscally expansive policy. The pair has been holding with about 1.3030-50, off from the two-week high of last Thursday at 1.3069. AUD-USD has traded slightly firmer, managing to lift just above its Friday high in making a peak at 0.6733. USD-CAD edged out a two-week low, at 1.3225. A big focus will be on flash manufacturing PMI surveys for February, due at the end of the week out of Eurozone, UK and U.S. Note that U.S. and Canadian markets are closed today.

Conference/Events
Azure Power management to meet with Roth Capital » 04:55
02/17/20
02/17
04:55
02/17/20
04:55
AZRE

Azure Power

$13.70 /

+0.21 (+1.56%)

Meetings to be held in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
FX Action: USD-CAD edged out a two-week low » 04:00
02/17/20
02/17
04:00
02/17/20
04:00

FX Action: USD-CAD edged…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Update: The dollar and most other currencies have been stable » 03:40
02/17/20
02/17
03:40
02/17/20
03:40

FX Update: The dollar and…

FX Update: The dollar and most other currencies have been stable in quiet early-week trading so far. This came with the main Chinese equity indices posting 2%-plus gains after China's Finance Minister said on Sunday that Beijing would roll out targeted and phased tax and fee cuts and with the PBoC lowering one of its interest rates and making another liquidity injection. Other stock markets in Asia were mixed. The number of new cases in the coronavirus continued to increased, though the consensus view seems to remain that peak contagion will likely been seen in March. Japan's Nikkei 225 underperformed, closing with a 0.7% loss following weaker than expected Q4 GDP data, which showed a 1.6% q/q contraction versus the median forecast for -0.9%. Q3 data were also revised down, and the data come amid expectations for a dismal current quarter performance given the impact of measures to contain the virus outbreak in China and Japan, and elsewhere. Among the main currencies, EUR-USD has been plying a narrow range just above the 34-month seen on Friday at 1.0827. EUR-JPY and EUR-CHF have been doing likewise about their respective four-month and five-year lows of Friday. USD-JPY has posted a sub-15 pip range just below Friday's 107.91 peak so far. Cable has continued to consolidate gains seen mid last week following signs that the government is gearing up a fiscally expansive policy. The pair has been holding with about 1.3030-50, off from the two-week high of last Thursday at 1.3069. AUD-USD has traded slightly firmer, managing to lift just above its Friday high in making a peak at 0.6733. USD-CAD edged out a two-week low, at 1.3233. A big focus will be on flash manufacturing PMI surveys for February, due at the end of the week out of Eurozone, UK and U.S. Note that U.S. markets will be closed today.

General news
Asian Market Update: » 03:05
02/17/20
02/17
03:05
02/17/20
03:05

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Paramount Group management to meet with Morgan Stanley » 16:42
02/16/20
02/16
16:42
02/16/20
16:42
PGRE

Paramount Group

$14.84 /

+0.15 (+1.02%)

Group Dinner Meeting with…

Group Dinner Meeting with President & CEO Behler and CFO Paes will be held in New York on February 25 hosted by Morgan Stanley.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
8x8, Inc. management to meet with Morgan Stanley » 16:38
02/16/20
02/16
16:38
02/16/20
16:38
EGHT

8x8, Inc.

$20.41 /

-0.25 (-1.21%)

Meeting to be held in New…

Meeting to be held in New York on February 20 hosted by Morgan Stanley.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Bausch Health management to meet with Morgan Stanley » 16:36
02/16/20
02/16
16:36
02/16/20
16:36
BHC

Bausch Health

$27.74 /

+0.305 (+1.11%)

Meeting to be held in New…

Meeting to be held in New York on February 19 hosted by Morgan Stanley.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Piper Sandler biotech analyst to hold a KOL luncheon » 16:04
02/16/20
02/16
16:04
02/16/20
16:04

Analysts hold a GU…

Analysts hold a GU Oncology Key Opinion Leader Luncheon Meeting with Dr. Arjun Bala in New York on February 21 hosted by Piper Sandler.

Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call » 16:03
02/16/20
02/16
16:03
02/16/20
16:03

Alternative Energy &…

Alternative Energy & Environmental Services Analyst Windham discusses advanced nuclear energy systems with TerraPower on an Analyst/Industry conference call to be held on February 24 at 11 am.

Conference/Events
Cowen Washington policy strategist to hold an analyst/industry conference call » 16:01
02/16/20
02/16
16:01
02/16/20
16:01

Washington Research…

Washington Research Policy Strategist Krueger holds U.S. Blues: Delegate Download--Morning After (Nevada) Analyst/Industry conference call to be held on February 24 at 10:30 am.

Conference/Events
Stephens oil and gas analysts to hold an analyst/industry conference call » 15:59
02/16/20
02/16
15:59
02/16/20
15:59

Oil & Gas Analysts,…

Oil & Gas Analysts, along with Brandon Barnes, Senior Analyst for Bloomberg Intelligence, discuss the current state of the energy-related infrastructure in North America, with a specific focus on oil & gas pipeline construction on an Analyst/Industry conference call to be held on February 18 at 11 am.

Conference/Events
Cantor Fitzgerald biotech & specialty pharma analysts to hold a luncheon » 15:57
02/16/20
02/16
15:57
02/16/20
15:57
PFE

Pfizer

$36.49 /

-0.43 (-1.16%)

, LLY

Eli Lilly

$141.13 /

-0.75 (-0.53%)

, DERM

Dermira

$18.75 /

+0.01 (+0.05%)

, REGN

Regeneron

$399.34 /

+0.57 (+0.14%)

, INCY

Incyte

$78.42 /

+0.34 (+0.44%)

, ARNA

Arena Pharmaceuticals

$54.01 /

+0.18 (+0.33%)

Specialty Pharma Analyst…

Specialty Pharma Analyst Chen, Biotech Analysts Young & Merle, along with Key Opinion Leaders Dr. Goldberg, Skin Laser & Surgery Specialists of NY & NJ and Dr. Weinberg, Forest Hills Dermatology Group, discuss the competitive landscape in atopic dermatitis at a Group Luncheon Meeting being held at Cantor's New York offices on February 24 at 12 pm.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Cellcom Israel announces negotiations to purchase Golan Telecom » 15:27
02/16/20
02/16
15:27
02/16/20
15:27
CEL

Cellcom Israel

$4.04 /

-0.08 (-1.94%)

Cellcom Israel announced…

Cellcom Israel announced that it is in negotiations with Golan Telecom's, or Golan Telecom, shareholders, in regards to possible purchase of its holdings in Golan Telecom. The company added that it cannot guarantee that such discussions will mature into a transaction.

Hot Stocks
Bristol-Myers announced five-year follow-up results from Phase 3 CheckMate -025 » 15:25
02/16/20
02/16
15:25
02/16/20
15:25
BMY

Bristol-Myers

$66.38 /

+0.31 (+0.47%)

Bristol-Myers Squibb…

Bristol-Myers Squibb announced five-year follow-up results from the Phase 3 CheckMate -025 study, which continue to demonstrate that treatment with Opdivo delivers superior overall survival and objective response rates in patients with previously treated advanced or metastatic renal cell carcinoma compared to those treated with everolimus. With an extended minimum follow-up of 64 months, patients treated with Opdivo continue to demonstrate OS benefit with 26% of patients alive compared to 18% of patients treated with everolimus. Additionally, the percentage of patients experiencing an objective response was 23% for Opdivo versus 4% for everolimus and the median duration of response for Opdivo was also maintained longer than for everolimus. The overall safety profile was consistent with that observed in previously reported analyses from CheckMate -025 in patients with RCC. No new safety signals or drug-related deaths occurred with extended follow-up.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Bristol-Myers announced updated results from Phase 3 CheckMate -214 study » 15:23
02/16/20
02/16
15:23
02/16/20
15:23
BMY

Bristol-Myers

$66.38 /

+0.31 (+0.47%)

Bristol-Myers Squibb…

Bristol-Myers Squibb announced updated results from the Phase 3 CheckMate -214 study evaluating the combination of Opdivo plus Yervoy versus sunitinib in patients with previously untreated advanced or metastatic renal cell carcinoma. With a minimum follow-up of 42 months, the combination of Opdivo plus Yervoy continues to show superior overall survival, objective response rates, duration of response and complete response rates. The safety profile for Opdivo plus Yervoy was consistent with prior findings and no new safety signals or drug-related deaths occurred with extended follow-up. A significant OS benefit was observed in both patients from the intermediate- and poor-risk and the intent-to-treat populations treated with Opdivo plus Yervoy compared to those treated with sunitinib alone. Of the patients treated with Opdivo plus Yervoy who experienced a complete response, per independent review, that response was ongoing in 84% and 86% of patients in the IP and ITT populations, respectively.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.